rs198977
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_005551.5(KLK2):c.748C>T(p.Arg250Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.248 in 1,613,356 control chromosomes in the GnomAD database, including 51,656 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in UniProt.
Frequency
Consequence
NM_005551.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KLK2 | NM_005551.5 | c.748C>T | p.Arg250Trp | missense_variant | 5/5 | ENST00000325321.8 | NP_005542.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.297 AC: 45087AN: 151848Hom.: 7255 Cov.: 32
GnomAD3 exomes AF: 0.244 AC: 61217AN: 251292Hom.: 8116 AF XY: 0.239 AC XY: 32510AN XY: 135812
GnomAD4 exome AF: 0.243 AC: 354835AN: 1461390Hom.: 44384 Cov.: 33 AF XY: 0.240 AC XY: 174451AN XY: 727032
GnomAD4 genome AF: 0.297 AC: 45135AN: 151966Hom.: 7272 Cov.: 32 AF XY: 0.295 AC XY: 21910AN XY: 74264
ClinVar
Submissions by phenotype
Acute myeloid leukemia Pathogenic:1Benign:1
Pathogenic, no assertion criteria provided | research | Shandong Key Laboratory of Immunohematology, Qilu Hospital, Shandong University | - | - - |
Benign, criteria provided, single submitter | research | Eleanor M. Freitas Health Laboratory | Jul 22, 2023 | The genetic Variant 'Arg250Trp' within the KLK2 Gene is too frequent to be classified as pathogenic, according to the ACMG guidelines (Richards et al., 2015) this variant meets the following criteria: BA1 (Stand Alone), as it is present in GnomAD exomes with an allele frequency of 0.243, which in turn, is greater than the minimum threshold requirement of >0.05 (with good coverage in gnomAD exomes = 42.9). It also satisfies additional supportive ACMG criteria, such as BP4 (benign-supportive ) with in-silico predictions classifying this variant as 'very strong benign' (meta-score (MetaRNN = 0.000294), which is less than the 0.00692 threshold cut-off. Lastly, an additional "benign supportive" BP6 criterion also been satisfied, due to independent review by Uniprot (VAR_020178) which assessed and classified this variant as 'Likely Benign/Benign' (LB/B). I also refer to a previous study with Meng. et al. (2023) which asserts rs198977 (genotype TT) as being 'associated with an increased risk of AML susceptibility'. However, this study seriously lacks the sufficient and robust sample size required to reach an appropriate conclusion (specifically in respect to the size of the TT genotype sub-group. This in turn, may result in a lower statistical power and yield unreliable estimates regarding the disease-association in question. Moreover there is no mention of specific population demographics used in the study, and this further raises questions about the population diversity recruited in this study. Notwithstanding, the current lack of in-vitro & in-vivo studies to support their results. This means results may suffer a serious lack of reproducibility relating to proving the variant-disease association relating to these results, let alone the specific genotype relating to the variant and the disease. In conclusion the high allele frequency of 0.243 effectively disqualifies this variant from being classified as pathogenic, in accordance with ACMG guidelines and current evidence available (at the time of this variant classification). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at